Nicaragua vs Sur: HIV-positive TB patients on ART (antiretroviral therapy)
Nicaragua
100.0%
in 2023
Sur
82.0%
in 2024
Nicaragua rank
1st
Sur rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Nicaragua
- Sur
How they compare
Nicaragua currently reports 100.0% against 82.0% in Sur, a difference of 18.0%.
That makes Nicaragua's figure about 1.2 times Sur's.
Across all 14 years both countries report, Nicaragua has been ahead every year.
Nicaragua ranks 1st and Sur ranks 2nd of 144 countries.
Nicaragua has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nicaragua | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.0% | 41.0% | 56.0% | Nicaragua |
| 2010s | 87.4% | 66.5% | 20.9% | Nicaragua |
| 2020s | 98.2% | 74.2% | 24.0% | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Nicaragua or Sur?
- Nicaragua, at 100.0% against 82.0% in Sur as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Nicaragua and Sur?
- 18.0%, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Sur?
- 14 years are reported by both, from 2008 to 2023.
- How do Nicaragua and Sur rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Nicaragua ranks 1st and Sur ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.